CDRH postmarket reengineering team
This article was originally published in The Gray Sheet
Executive Summary
Thirteen-member group is conducting weekly meetings to collect feedback on postmarket surveillance and discuss potential initiatives. Brian Harvey, CDRH Office of Device Evaluation, co-heads the team with Tom Gross from the Office of Surveillance and Biometrics. After presenting project ideas to outgoing center Director Bruce Burlington Feb. 19, the team will split into subgroups to design pilot programs in areas such as MDR reporting, device tracking, surveillance and Sentinel reporting. The pilots should be in place by early summer
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.